Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Odinwell AB (0AF.F)

Compare
0.0420
+0.0010
+(2.44%)
At close: April 9 at 3:29:02 PM GMT+2
Loading Chart for 0AF.F
  • Previous Close 0.0410
  • Open 0.0442
  • Bid 0.0416 x --
  • Ask 0.0556 x --
  • Day's Range 0.0408 - 0.0442
  • 52 Week Range 0.0285 - 0.3180
  • Volume 1,800
  • Avg. Volume 0
  • Market Cap (intraday) 1.264M
  • Beta (5Y Monthly) -0.31
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Odinwell AB engages in the research and development of patented optical sensor technology for the development of smart wound care dressings in Sweden. It develops smart wound care for bandages and plasters. Odinwell AB was incorporated in 2019 and is based in Halmstad, Sweden.

odinwell.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0AF.F

View More

Performance Overview: 0AF.F

Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

0AF.F
84.44%
OMX Stockholm 30 Index (^OMX)
12.38%

1-Year Return

0AF.F
22.94%
OMX Stockholm 30 Index (^OMX)
13.44%

3-Year Return

0AF.F
88.37%
OMX Stockholm 30 Index (^OMX)
2.06%

5-Year Return

0AF.F
92.28%
OMX Stockholm 30 Index (^OMX)
45.17%

Compare To: 0AF.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0AF.F

View More

Valuation Measures

Annual
As of 4/8/2025
  • Market Cap

    1.23M

  • Enterprise Value

    653.69k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    0.33

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -110.29%

  • Return on Assets (ttm)

    -10.56%

  • Return on Equity (ttm)

    -14.34%

  • Revenue (ttm)

    4.76M

  • Net Income Avi to Common (ttm)

    -5.25M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.38M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -8.71M

Research Analysis: 0AF.F

View More

Company Insights: 0AF.F

Research Reports: 0AF.F

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.